Vor Biopharma Inc. (VOR) Tops Q4 EPS by 7c

Vor Biopharma Inc. (NASDAQ: VOR) reported Q4 EPS of ($0.53), $0.07 better than the analyst estimate of ($0.60).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c